文献速递乳腺癌放疗放疗物理与技术

最小乳腺距离在很大程度上解释乳腺癌放疗对侧乳腺剂量的个体差异

Minimum breast distance largely explains individual variability in doses to contralateral breast from breast-cancer radiotherapy.
PubMed 文献 · Radiother Oncol · 2018-09-18

研究对128例乳腺癌患者计划全乳放疗,采用三维适形、调强和混合技术,处方剂量50.4 Gy,评估17项解剖指标与对侧乳腺剂量体积特征的关系。多野调强放疗对侧乳腺平均剂量为0.8-7.1 Gy,与所研究解剖参数无相关性;切线全乳照射对侧乳腺平均剂量低得多,为0.2-1.6 Gy,其中约60%的个体间变异可由最小乳腺距离解释,最小乳腺距离每增加1 cm,对侧乳腺平均剂量降低10-15%。

要点

  • 多野调强放疗对侧乳腺平均剂量0.8-7.1 Gy,与所研究解剖参数无相关性。
  • 切线全乳照射对侧乳腺平均剂量0.2-1.6 Gy,约60%个体间变异由最小乳腺距离解释。
  • 最小乳腺距离每增加1 cm,对侧乳腺平均剂量降低10-15%。

核心结论

  • 基于CT可评估的参数可实现对切线全乳照射对侧乳腺剂量的个体化评估,可能有助于支持临床决策过程以及分析关于对侧乳腺风险的回顾性研究。

研究设计与样本

  • 对128例乳腺癌患者计划全乳放疗,采用三维适形、调强和混合技术,处方剂量50.4 Gy。
  • 从患者CT图像评估17项解剖指标,并通过模型拟合检验其作为对侧乳腺剂量体积特征预测因素。

主要发现

  • 多野调强放疗对侧乳腺平均剂量为0.8-7.1 Gy,与所研究解剖参数无相关性。
  • 切线全乳照射对侧乳腺平均剂量低得多,为0.2-1.6 Gy。
  • 约60%的个体间变异由单一解剖指标即最小乳腺距离的个体差异解释;最小乳腺距离每增加1 cm,对侧乳腺平均剂量降低10-15%。
  • 作为最小乳腺距离的替代,剂量估算可基于乳腺间距,其与最小乳腺距离高度相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To provide personalized estimates of doses to contralateral breast (CB) from breast-cancer radiotherapy. METHODS: Whole-breast irradiations using 3D conformal, intensity-modulated and hybrid techniques with 50.4 Gy prescribed dose were planned for 128 breast-cancer patients. From their CT images, 17 anatomic measures were assessed and tested by model fitting as predictors for CB dose-volume characteristics. RESULTS: Multi-field intensity-modulated radiotherapy (IMRT) yielded mean CB doses of 0.8-7.1 Gy, with no correlation to the studied anatomic parameters. Tangential whole-breast irradiation led to much lower mean CB doses, 0.2-1.6 Gy. About 60% of this inter-patient variability was explained by individual variations in a single anatomic measure, the minimum breast distance (MBD), defined as the CB distance from the tangent to the treated breast. Per 1 cm increase in MBD, the mean CB dose decreased by 10-15%. As an alternative to MBD, dose estimates could be based on the breast-to-breast distance, which is highly correlated with MBD. CONCLUSION: The results enable personalized assessment of CB doses from tangential whole-breast irradiation, based only on parameters assessable from CT data. This may help support clinical decision-making processes as well as analyse retrospective studies on CB risks.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Kundrát P, Remmele J, Rennau H, et al. Minimum breast distance largely explains individual variability in doses to contralateral breast from breast-cancer radiotherapy. Radiother Oncol. 2018. PMID: 30241788. doi:10.1016/j.radonc.2018.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。